Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2010 Mar 24;5(2):210–219. doi: 10.1007/s11481-010-9199-6

Fig. 2.

Fig. 2

Systemic BCG infection leads to altered T-cell trafficking, thus suppressing a CNS autoimmune disease. Prior infection also reduces EAE clinical symptoms and the frequency of IFN-γ-producing MOG-specific T cells in the CNS. As a result of the chemokine and cytokine gradients generated by peripheral granuloma, activated auto-reactive T cells are diverted from their original effector sites and are detained in granuloma